Elizabeth Smith

SVP, Regulatory and Quality Assurance

Elizabeth Smith is our Senior Vice President, Regulatory and Quality Assurance, and joined Juno in November 2013. Ms. Smith has over 20 years of experience in the field of regulatory affairs, quality, and manufacturing, with an emphasis on biologics and advanced cellular therapies in oncology. Most recently, Ms. Smith served as the Vice President of Regulatory Affairs at Dendreon and led the regulatory efforts resulting in FDA licensure of Provenge, the first approved active cellular therapy for the treatment of cancer. Prior to Dendreon, Ms. Smith held regulatory and manufacturing positions at Genentech and Immunex. She holds B.A. in Biology from Central Washington University.